-63%

est. 2Y upside i

HealthcareSeries C

Stage: exit. Country: Germany

Rank

#2701

Sector

Healthcare EdTech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Lecturio, a Series C EdTech company with an estimated $18M in revenue, presents a moderate upside opportunity for a job seeker.

Last updated: March 10, 2026

Bull (15%)+180%

Lecturio successfully integrates recent acquisitions and accelerates global expansion, particularly in the high-growth corporate e-learning segment. Strong adoption of AI-powered tools and new content drives revenue to $45M by 2028, justifying a 10x revenue multiple and a $450M valuation, representing a 180% upside from the current estimated valuation.

Base (50%)+45%

Lecturio maintains its competitive position in digital healthcare education, achieving steady growth through content enhancements and moderate expansion. Revenue grows to $27M by 2028, sustaining an 8.8x revenue multiple and a $238M valuation, leading to a 45% upside.

Bear (35%)-50%

Increased competition from well-funded incumbents and slower-than-expected integration of acquisitions hinder growth. Revenue stalls at $20M by 2028, and a market downturn or competitive pressure contracts the valuation multiple to 4x, resulting in an $80M valuation and a 50% downside, significantly impacting common stock value due to liquidation preferences.

Est. time to liquidity~2.5 years

Preference Stack Risk

severe

Investors hold $49.2M in liquidation preferences ahead of common stock, representing 30.75% of the estimated current valuation of $160M.

Dilution Risk

moderate

As a Series C company, there is a moderate risk of further dilution from future funding rounds before a liquidity event.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Lecturio's shares.

Other 1 role

View all 1 open roles at Lecturio

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Lecturio's data — designed to show you've done your homework.

  • 1

    Given the strong competition from established players like UWorld and Kaplan, what is Lecturio's long-term strategy to differentiate and capture significant market share in both medical and nursing education?

  • 2

    Lecturio has made recent acquisitions like SimTutor and NEJM Healer. How are these integrations progressing, and what specific revenue or strategic synergies are you seeing from them, particularly in expanding into the corporate e-learning segment?

  • 3

    With $49.2M in total funding and a Series C round in 2021, how does the company envision its path to profitability and a potential liquidity event for employees, and what are the key milestones for the next 24 months?

Community

Valuation Sentiment

Our model estimates -63% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.